Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 30.80
-0.20 (-0.65%)
Sep 10, 2025, 12:40 PM CST
Sofiva Genomics Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -7.27 | 18.43 | 11.53 | 42.78 | 56.98 | 34.62 | Upgrade |
Depreciation & Amortization | 42.75 | 41.62 | 41.34 | 42.79 | 41.95 | 48.17 | Upgrade |
Loss (Gain) From Sale of Assets | 0.01 | - | - | -0.02 | - | -0 | Upgrade |
Loss (Gain) on Equity Investments | -25.67 | -25.35 | -23.67 | -41.9 | -31.05 | -17.5 | Upgrade |
Stock-Based Compensation | 0.03 | -0.73 | 1.07 | 2.68 | 2.87 | 1.87 | Upgrade |
Provision & Write-off of Bad Debts | -0.01 | - | 0 | -0.49 | -0.14 | -0.35 | Upgrade |
Other Operating Activities | -0.12 | 8.46 | -3.92 | -2.99 | 1.58 | -13.54 | Upgrade |
Change in Accounts Receivable | 21.68 | 5.6 | -2.23 | 0.94 | -12.39 | 2.33 | Upgrade |
Change in Inventory | 0.81 | -4.61 | 15.29 | -15.52 | 8.55 | -15.84 | Upgrade |
Change in Accounts Payable | -6.15 | -9.25 | -18.89 | -3.64 | 7.72 | 11.39 | Upgrade |
Change in Unearned Revenue | 1.01 | 1 | -1.34 | -0.58 | -0.56 | 0.69 | Upgrade |
Change in Other Net Operating Assets | -3.92 | -0.5 | 4.5 | -6.92 | 4.56 | 8.98 | Upgrade |
Operating Cash Flow | 23.16 | 34.69 | 23.7 | 17.14 | 80.07 | 60.82 | Upgrade |
Operating Cash Flow Growth | 651.56% | 46.38% | 38.30% | -78.60% | 31.65% | -39.69% | Upgrade |
Capital Expenditures | -2.57 | -16.92 | -21.01 | -33.53 | -8.16 | -15.47 | Upgrade |
Sale of Property, Plant & Equipment | -0.01 | - | - | 0.1 | - | 0 | Upgrade |
Sale (Purchase) of Intangibles | -6.87 | -7.2 | -3.55 | -2.17 | -4.49 | -0.45 | Upgrade |
Investment in Securities | 2.1 | 9.13 | 7.93 | -20.95 | - | -30.2 | Upgrade |
Other Investing Activities | -7.46 | 4.33 | 6.65 | 3.07 | 2.62 | -0.27 | Upgrade |
Investing Cash Flow | -14.81 | -10.66 | -9.99 | -53.48 | -10.03 | -46.38 | Upgrade |
Long-Term Debt Repaid | - | -15.81 | -14.74 | -15.75 | -15.54 | -15.42 | Upgrade |
Total Debt Repaid | -16.25 | -15.81 | -14.74 | -15.75 | -15.54 | -15.42 | Upgrade |
Net Debt Issued (Repaid) | -16.25 | -15.81 | -14.74 | -15.75 | -15.54 | -15.42 | Upgrade |
Issuance of Common Stock | 6.37 | 12.07 | - | - | 1.12 | 0.55 | Upgrade |
Common Dividends Paid | -4.27 | -4.27 | -21.36 | -42.73 | -29.77 | -55.17 | Upgrade |
Other Financing Activities | -0.55 | -0.55 | -0.57 | -0.18 | -0 | - | Upgrade |
Financing Cash Flow | -14.71 | -8.57 | -36.67 | -58.65 | -44.19 | -70.05 | Upgrade |
Foreign Exchange Rate Adjustments | -0.11 | -0.19 | -0.05 | -0.18 | 0.29 | -0.5 | Upgrade |
Net Cash Flow | -6.46 | 15.27 | -23.01 | -95.18 | 26.14 | -56.11 | Upgrade |
Free Cash Flow | 20.6 | 17.77 | 2.69 | -16.4 | 71.91 | 45.35 | Upgrade |
Free Cash Flow Growth | - | 560.18% | - | - | 58.55% | -45.23% | Upgrade |
Free Cash Flow Margin | 5.07% | 3.92% | 0.58% | -3.31% | 14.14% | 9.28% | Upgrade |
Free Cash Flow Per Share | 0.96 | 0.82 | 0.13 | -0.77 | 3.38 | 2.12 | Upgrade |
Cash Interest Paid | 0.98 | 1.07 | 1.24 | 1.44 | 1.69 | 1.92 | Upgrade |
Cash Income Tax Paid | - | -3.23 | 1.34 | 7.61 | 5.19 | 16.25 | Upgrade |
Levered Free Cash Flow | 28.5 | 10.12 | 2.66 | -20.41 | 63.61 | 34.08 | Upgrade |
Unlevered Free Cash Flow | 29.14 | 10.81 | 3.47 | -19.48 | 64.7 | 35.31 | Upgrade |
Change in Working Capital | 13.44 | -7.75 | -2.66 | -25.72 | 7.88 | 7.55 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.